US FDA Seeks Benzene Testing Of 200 Drug Products By Contract Lab
Executive Summary
The agency is calling for an ISO 17025-accredited or equivalent partner to screen selected drug products for benzene, following a rash of sunscreen, antiperspirant and other OTC drug product recalls which triggered a rush on testing laboratories, as well as class action filings across the US.
You may also be interested in...
Benzene Suits Against US Personal-Care Firms Appear Headed In One Direction: Settlement
The latest in litigation against Unilever, P&G, Beiersdorf and J&J alleging violations for selling personal-care products contaminated with benzene.
US FDA Advises Drug Firms To Test For Benzene Contamination As Root-Cause Investigation Continues
The FDA offers insight into possible sources of benzene contamination in drug products, including aerosol spray propellants, carbomers, or other drug components made from hydrocarbons. Manufacturers that find benzene in drug product batches at levels exceeding 2 ppm should not release the product or, if already in distribution, discuss with the FDA initiating a voluntary recall.
Valisure’s Findings Of Benzene In Body Sprays Suggest Ongoing Aerosol Propellant Problem
Hydrocarbon-based propellants can harbor trace levels of benzene, among other impurities, when quality controls are insufficient. Leading brands’ antiperspirant and deodorant body sprays are the latest aerosol personal-care products identified by independent laboratory Valisure as contaminated with the carcinogen.